This study is in progress, not accepting new patients
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Hepatocellular Carcinoma Gastrointestinal Cancer Metastatic Neuroendocrine Tumors Hypoxia Embolization Tirapazamine Carcinoma, Hepatocellular Liver Neoplasms Gastrointestinal Neoplasms Transarterial embolization (TAE)
Lead Scientist at UCSF
- Nicholas Fidelman
Nicholas Fidelman, MD, is an Associate Professor of Clinical Radiology at the University of California, San Francisco and UCSF Mount Zion. Dr. Fidelman received his medical degree from UCSF in 2002, and completed his residency in Diagnostic Radiology from UCSF in 2007, followed by a fellowship in Interventional Radiology from UCSF in 2008.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Teclison Ltd.
- Phase 1/2
- Study Type
- Last Updated